Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner. by Oscar Holmström, Nina Linder, Mikael Lundin, Hannu Moilanen, Antti Suutala, Riku Turkki, Heikki Joensuu, Jorma Isola, Vinod Diwan, Johan Lundin

Get full text

Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan by Negar Pourjamal, Vadim Le Joncour, György Vereb, Cilla Honkamaki, Jorma Isola, Jeffrey V Leyton, Pirjo Laakkonen, Heikki Joensuu, Mark Barok

Get full text

Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering by Olga Bednova, Jessica Pougoue Ketchemen, Hazem Mslati, Mark Barok, Heikki Joensuu, Natalie Zeytuni, Francesco Gentile, Leon Sanche, Humphrey Fonge, Jeffrey Victor Leyton

Get full text

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization by Vadim Le Joncour, Pauliina Filppu, Maija Hyvönen, Minna Holopainen, S Pauliina Turunen, Harri Sihto, Isabel Burghardt, Heikki Joensuu, Olli Tynninen, Juha Jääskeläinen, Michael Weller, Kaisa Lehti, Reijo Käkelä, Pirjo Laakkonen

Get full text

Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD d... by Roberto D’Amico, Valentina Guarneri, PierFranco Conte, Heikki Joensuu, Xavier Pivot, Vassilis Georgoulias, Louise Hiller, Janet A Dunn, Mubarak Patel, Teppo Huttunen, Helena M Earl, Dora Hatzidaki, Jean E Abraham, David Miles, David A Cameron, Andrew M Wardley

Get full text